Faruqi and Faruqi, LLP has opened an investigation into potential securities claims against Beta Bionics Inc., examining whether the company made misleading statements or failed to disclose information important to investors. The move follows a sharp drop in Beta Bionics shares after the company said it expected fewer fourth-quarter patient starts than analysts had estimated.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030922PRIMZONEFULLFEED9664421) on March 03, 2026, and is solely responsible for the information contained therein.